Europe (WHO region) vs Qatar: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Europe (WHO region)
89.0%
in 2025
Qatar
99.0%
in 2025
Europe (WHO region) rank
3rd
Qatar rank
1st
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Europe (WHO region)
- Qatar
How they compare
Qatar currently reports 99.0% against 89.0% in Europe (WHO region), a difference of 10.0%.
That makes Qatar's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 3 times across 26 shared years of data; in 2000 it was Europe (WHO region) ahead.
Europe (WHO region) ranks 3rd and Qatar ranks 1st of 11 groups.
Qatar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Europe (WHO region) | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70.6% | 74.7% | 4.1% | Qatar |
| 2010s | 87.3% | 95.9% | 8.6% | Qatar |
| 2020s | 89.5% | 97.2% | 7.7% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Europe (WHO region) or Qatar?
- Qatar, at 99.0% against 89.0% in Europe (WHO region) as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Europe (WHO region) and Qatar?
- 10.0%, with Qatar ahead.
- How many years of comparable data are there for Europe (WHO region) and Qatar?
- 26 years are reported by both, from 2000 to 2025.
- How do Europe (WHO region) and Qatar rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Europe (WHO region) ranks 3rd and Qatar ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.